William Quirk analyst

Currently out of the existing stock ratings of William Quirk, 176 are a BUY (72.73%), 65 are a HOLD (26.86%), 1 are a SELL (0.41%).

William Quirk

Work Performance Price Targets & Ratings Chart

Analyst William Quirk, carries an average stock price target met ratio of 89.46% that have a potential upside of 30.25% achieved within 408 days. Previously, William Quirk worked at PIPER SANDLER.

William Quirk’s has documented 492 price targets and ratings displayed on 30 stocks. The coverage was on Basic Materials, Healthcare, Financial Services sectors.

Most recent stock forecast was given on BDX, Becton Dickinson and Company at 05-May-2023.

Wall Street Analyst William Quirk

Analyst best performing recommendations are on FLGT (FULGENT GENETICS).
The best stock recommendation documented was for FLGT (FULGENT GENETICS) at 11/5/2019. The price target of $12.3 was fulfilled within 1 day with a profit of $0.71 (5.46%) receiving and performance score of 54.57.

Average potential price target upside

AVTR Avantor AXDX Accelerate Diagnostics BDX Becton Dickinson and Company CDNA Caredx FLDM Fluidigm FLGT Fulgent Genetics HOLX Hologic LH Laboratory of America Holdings LMNX Luminex MASI Masimo MYGN Myriad Genetics OCX OncoCyte Corp PACB Pacific Biosciences of California PKI PerkinElmer GHDX Genomic Health ILMN Illumina DGX Quest Diagnostics NTRA Natera QGEN Qiagen NV EW Edwards Lifesciences Corp QDEL Quidel OXFD Oxford Immunotec Global PLC A Agilent Technologies DHR Danaher HSKA Heska VCYT Veracyte VIVO Meridian Bioscience LAB Standard Biotools AX Axos Financial RVTY Revvity

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Jul-2020

$18

$1.95 (12.15%)

$17

Hold Since 04-Aug-2025

$18

$1.95 (12.15%)

$15

Sell Since 15-Apr-2026

$16

$-0.05 (-0.31%)

$15

Hold Since 04-Aug-2025

$17

$0.95 (5.92%)

$9

Buy Since 11-Jun-2019

$16

$-0.05 (-0.31%)

$14

3 months 1 days ago
(30-Jul-2026)

6/10 (60%)

$2.14 (15.44%)

223

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?